Spain broadens use of AstraZeneca jab to adults under age 65

MADRID (AP) — Spain’s health minister says the country will resume the use of the AstraZeneca coronavirus vaccine on Wednesday by extending it to adults under age 65.

Authorities will consider giving it to older people after they analyze a U.S. study that AstraZeneca said showed the jab provides strong protection to all adults, Spanish Health Minister Carolina Darias said Monday.

Disclosing the results of a long-anticipated study, the British-Swedish drugmaker said its vaccine was 79% effective overall at preventing symptomatic cases of COVID-19, including in older people, and that none of the more than 30,000 volunteers in the U.S. study were hospitalized or developed severe COVID-19.

Speaking to reporters during a weekly briefing, Darias said Spanish officials need more time to analyze all the information from the study before broadening the use of the vaccine, something that several regions and doctors have demanded for weeks.

Like several other European countries, Spain stopped administering the AstraZeneca vaccine last week. The European Union's drug regulator later declared the vaccine safe and with no obvious links to a few dozen cases of rare blood clots.

Central and regional health officials in Spain cleared the way for resuming shots of the AstraZeneca vaccine and also approved administering the vaccine to people ages 18-65.

“Vaccines are safe, effective and they save lives,” Darias said.

Citing a lack of studies on its performance in older people, Spain had previously restricted its use in adults under 55 years old.

The health minister also warned that the latest pandemic data suggests another sharp increase in infections could be around the corner. Authorities are trying to free up hospital intensive care units treating COVID-19 patients.

Official...